Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
ACTIVE_NOT_RECRUITING
Status
Conditions
- Breast Carcinoma
- Carcinoma of Unknown Primary
- Endometrial Carcinoma
- Esophageal Carcinoma
- Liver Failure
- Lung Carcinoma
- Malignant Head and Neck Neoplasm
- Malignant Testicular Neoplasm
- Melanoma
- Metastatic Malignant Solid Neoplasm
- Ovarian Carcinoma
- Renal Failure
- Unresectable Malignant Neoplasm
- Urothelial Carcinoma
Interventions
- DRUG: Carboplatin
- OTHER: Laboratory Biomarker Analysis
- DRUG: Paclitaxel
- OTHER: Pharmacological Study
- DRUG: Veliparib
Sponsor
National Cancer Institute (NCI)
Collaborators